Nahdi Medical Company Nahdi Medical Company

Nahdi Medical Company

4164

Rank in Stocks #4860
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Share Price
$23.42
Market Cap
$3.05B
Change (1 day)
-0.45%
Change (1 year)
-27.09%
Country
SA
Trade Nahdi Medical Company (4164)

Category

Healthcare
Revenue for Nahdi Medical Company (4164)
Revenue in Jun 2026 TTM: $2.80B
According to Nahdi Medical Company latest financial reports the company's current revenue (TTM) is $2.80B. In 2023 the company made a revenue of $2.32B an increase over the revenue in the year 2022 that was $2.29B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nahdi Medical Company from 2017 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $2.80B 11.55%
2024 $2.51B 8.21%
2023 $2.32B 1.37%
2022 $2.29B 6.69%
2021 $2.15B -6.73%
2020 $2.30B 10.44%
2019 $2.09B 6.47%
2018 $1.96B 4.11%
2017 $1.88B 0.00%
Revenue for similar companies or competitors